Company Filing History:
2 out of 33 
2 out of 2 Years Active: 2023-2025
Title: Innovations by Thomas Duhen in Cancer Treatment
Introduction
Thomas Duhen is an accomplished inventor based in Portland, OR (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of two patents to his name, Duhen's work focuses on the utilization of specific T cells for therapeutic purposes.
Latest Patents
Duhen's latest patents include methods for treating subjects with tumors. These methods involve administering a therapeutically effective amount of CD8CD39CD103 T cells to the subject. Additionally, he has developed techniques for isolating a nucleic acid encoding a T cell receptor (TCR) that specifically binds to tumor cell antigens. His methods also encompass the isolation of CD8CD39CD103 T cells from samples of subjects with tumors expressing these antigens. Furthermore, Duhen's patents detail methods for expanding CD8CD39CD103 T cells and determining if a subject will respond to checkpoint inhibitors by detecting the presence of these T cells in biological samples.
Career Highlights
Throughout his career, Thomas Duhen has worked with notable organizations such as Providence Health & Services and Agonox, Inc. His experience in these companies has contributed to his expertise in the field of cancer research and treatment.
Collaborations
Duhen has collaborated with professionals like Andrew D. Weinberg and Rebekka Duhen, enhancing his research and development efforts in cancer therapies.
Conclusion
Thomas Duhen's innovative work in the field of cancer treatment showcases his dedication to improving therapeutic methods through the utilization of T cells. His patents reflect a significant advancement in the identification and treatment of tumors, contributing to the ongoing fight against cancer.